PMID: 3773355Mar 1, 1986Paper

Behavioral hypersensitivity to apomorphine after chronic methamphetamine--intermittent vs. continuous regimen

The Japanese Journal of Psychiatry and Neurology
K KashiharaS Otsuki

Abstract

The effects of chronic methamphetamine (MAP) on the behavioral response to apomorphine were examined in rats, treated with saline (control) or MAP for 14 days either intermittently (4 mg/kg/day, once daily) or continuously (subcutaneously implanted osmotic pumps releasing 56 mg/kg/14 days). Following a 7-day interval after discontinuing the MAP treatment, a challenge dose (0.5 mg/kg) of apomorphine was administered. The rats treated with MAP intermittently showed a marked augmentation in behavioral response to apomorphine than the continuous MAP group and control. It is presumed that the intermittent MAP administration may produce greater reactivity in the brain dopaminergic systems than the continuous administration.

References

Dec 1, 1978·Neuropharmacology·L R Nelson, G Ellison
Aug 1, 1972·The Biochemical Journal·J CaldwellR T Williams
Mar 1, 1974·Pharmacology, Biochemistry, and Behavior·D S Segal, A J Mandell
Mar 1, 1984·Pharmacology, Biochemistry, and Behavior·L Kokkinidis
Dec 1, 1981·Pharmacology, Biochemistry, and Behavior·M Hirabayashi, M R Alam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.